Browsing by Author Fernández-de-Trocóniz, J.I. (José Ignacio)

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleTypeAuthor(s)
2021A quantitative systems pharmacology model for acute viral hepatitis BArticuloFernández-de-Trocóniz, J.I. (José Ignacio); Asín-Prieto, E. (Eduardo); Parra-Guillen, Z.P. (Zinnia Patricia); Gómez-Mantilla, J.D. (José David); Vandenbossche, J. (Joris); Stuyckens, K. (Kim); De-Trixhe, X. (Xavier); Pérez-Ruixo, J.J. (Juan José)
2017Advanced Boolean modeling of biological networks applied to systems pharmacologyArticuloFernández-de-Trocóniz, J.I. (José Ignacio); Irurzun-Arana, I. (Itziar); Pastor-Gutierrez, J.M. (José Martín); Gómez-Mantilla, J.D. (José David)
2020Beyond Deterministic Models in Drug Discovery and DevelopmentArticuloFernández-de-Trocóniz, J.I. (José Ignacio); Irurzun-Arana, I. (Itziar); Rackauckas, C. (Christopher); McDonald, T.O. (Thomas O.)
2020Disease pharmacokinetic–pharmacodynamic modelling in acute intermittent porphyria to support the development of mRNA-based therapiesArticuloFernández-de-Trocóniz, J.I. (José Ignacio); Parra-Guillen, Z.P. (Zinnia Patricia); Fontanellas-Romá, A. (Antonio); Jericó-Asenjo, D. (Daniel); Martini, P. (Paolo); Vera-Yunca, D. (Diego); Hard, M. (Marjie); Guey, L. T. (Lin); Jiang, L. (Lei)
9-Jan-2024Mechanistic modelling of immuno-modulators in oncology drug developmentTesisSancho-Araiz, A. (Aymara)
2019Model-Informed Dose Selection for Xentuzumab, a Dual Insulin-Like Growth Factor-I/II—Neutralizing AntibodyArticuloFernández-de-Trocóniz, J.I. (José Ignacio); Parra-Guillen, Z.P. (Zinnia Patricia); Schmid, U. (Ulrike); Janda, A. (Álvaro); Freiwald, M. (Matthias)
2018Optimal dynamic control approach in a multi-objective therapeutic scenario: Application to drug delivery in the treatment of prostate cancerArticuloFernández-de-Trocóniz, J.I. (José Ignacio); Irurzun-Arana, I. (Itziar); Janda, A. (Álvaro); Ardanza-Trevijano, S. (Sergio)
2016Population Pharmacokinetic Analysis of Lanreotide Autogel®/Depot in the Treatment of Neuroendocrine Tumors: Pooled Analysis of Four Clinical TrialsArticuloFernández-de-Trocóniz, J.I. (José Ignacio); Buil-Bruña, N (Núria); Garrido, M.J. (María Jesús); Dehez, M. (Marion); Manon, A. (Amandine); Quyen-Nguyen, T.X. (Thi Xuan); Gómez-Panzani, E.L. (Edda L.)